Clinical Trial Results:
A 26 week randomised, open labelled, parallel group, multi-national, treat-to-target trial comparing efficacy and safety of insulin detemir once daily in combination
with sitagliptin and metformin versus sitagliptin and metformin with or without sulphonylurea, in subjects with type 2 diabetes.
Summary
|
|
EudraCT number |
2008-001050-40 |
Trial protocol |
FR HU SK FI |
Global completion date |
27 Aug 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Feb 2016
|
First version publication date |
02 Aug 2014
|
Other versions |
|
Summary report(s) |
Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.